Harald Gröger Selected Research

Vildagliptin

1/2022

Process Development of the Copper(II)-Catalyzed Dehydration of a Chiral Aldoxime and Rational Selection of the Co-Substrate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harald Gröger Research Topics

Disease

11	Dehydration (Water Stress) 04/2024 - 01/2017
1	Multiple Sclerosis 01/2019
1	Neoplasms (Cancer) 11/2018

Drug/Important Bio-Agent (IBA)

7	OximesIBA 04/2023 - 01/2017
7	NitrilesIBA 04/2023 - 01/2017
5	acetaldehyde oxime (acetaldoxime)IBA 04/2023 - 01/2018
4	EnzymesIBA 04/2023 - 01/2019
4	aldoxime dehydrataseIBA 01/2022 - 01/2019
3	Hydro-Lyases (Dehydratases)IBA 04/2023 - 01/2018
2	AldehydesIBA 01/2022 - 01/2019
2	Cyanides (Isocyanides)IBA 03/2021 - 01/2017
1	AlcoholsIBA 04/2024
1	MetalsIBA 01/2022
1	prolinalIBA 01/2022
1	saxagliptin FDA Link 01/2022
1	VildagliptinIBA 01/2022
1	CopperIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	cupric acetate (copper(II) acetate)IBA 01/2022
1	EmulsionsIBA 01/2021
1	Hydroxylamine (Hydroxylamine Hydrochloride)IBA 01/2019
1	ozanimodIBA 01/2019
1	2-(2'-pyridyldithio)benzyldiazoacetateIBA 11/2018